
Composition:
Each ml of Loxtra contains: Ofloxacin 3.0 mg, Prednisolone Acetate 2.0 mg, Tetrahydrozoline Hydrochloride 0.4 mg, Benzalkonium Chloride 0.05 mg (as preservative), HPMC as a vehicle.
Indications:
Loxtra Sterile Ophthalmic Suspension is indicated for:
For corticosteriod responsive inflammatory conditions of the conjunctiva, cornea and anterior segment of the eye where bacterial infection or a risk of bacterial infection exists.
Presentation:
Loxtra Sterile Ophthalmic Suspension, in 5 ml LDPE bottle.